Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

AIMS: Cilostazol (CLS) has shown antidepressant effect in cardiovascular patients, post‐stroke depression, and animal models through its neurotrophic and antiinflammatory activities. Consequently, we aimed to investigate its safety and efficacy in patients with MDD by conducting double‐blind, random...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Mahmoud S., Ramadan, Ahmed N., Omara‐Reda, Hend, Mansour, Noha O., Elsokary, Mohamed A., Elsawah, Hozaifa K., Zaki, Shimaa Abdelsattar, Abo Mansour, Hend E., Mosalam, Esraa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611782/
https://www.ncbi.nlm.nih.gov/pubmed/34545997
http://dx.doi.org/10.1111/cns.13731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611782/
https://www.ncbi.nlm.nih.gov/pubmed/34545997
http://dx.doi.org/10.1111/cns.13731

Ejemplares similares